| Malignant Glioma studied in …STUDIED_INderived200 of 2,053show all (up to 200) |
|---|
| → studied in | NCT05685004Phase 2/Phase 3 · active not recruiting Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864534Phase 2 · active not recruiting Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05871021Phase 2 · active not recruiting Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902169Phase 3 · recruiting Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325683Phase 2 · suspended Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303467Phase 1 · recruiting A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432804Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07145112Phase 1 · recruiting Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326566Phase 2 · recruiting Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416188Phase 1/Phase 2 · recruiting Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896568Phase 1 · recruiting MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05099003Phase 1/Phase 2 · recruiting A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183204Phase 2 · completed Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195591Phase 3 · recruiting Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422896Phase 1 · not yet recruiting A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115761Phase 2 · recruiting Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635734Phase 1/Phase 2 · completed Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07568782not yet recruiting Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers. · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05353530Phase 1 · active not recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389591Phase 1 · recruiting RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06558214Phase 2 · recruiting OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07031765Phase 1 · active not recruiting Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07515924early Phase 1 · not yet recruiting Oral Gallium Maltolate for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708961Phase 2 · suspended Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821112Phase 2 · not yet recruiting Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile® · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05109728Phase 1 · active not recruiting A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05555550early Phase 1 · recruiting Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765812Phase 1/Phase 2 · recruiting A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832448NA · active not recruiting Microsurgical Resection Combined With Photodynamic Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03223103Phase 1 · active not recruiting Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977375Phase 1/Phase 2 · recruiting Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838676Phase 2 · recruiting ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831161NA · not yet recruiting Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831187Phase 1/Phase 2 · not yet recruiting Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831772NA · recruiting REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587038Phase 1 · active not recruiting OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077735Phase 2 · active not recruiting Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07089641Phase 1 · recruiting ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277638Phase 1/Phase 2 · completed Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816927Phase 2 · recruiting Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03535350Phase 1 · active not recruiting Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974621Phase 2 · active not recruiting Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03115333NA · active not recruiting DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05495295Phase 1 · active not recruiting First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129760NA · suspended Glioblastoma Remote Monitoring and Care - Research Protocol · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132438Phase 1 · recruiting Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704858Phase 1/Phase 2 · active not recruiting Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771806recruiting Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797661NA · recruiting Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions. · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870944Phase 1/Phase 2 · recruiting CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma, H3 K27-Altered | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349693Phase 2/Phase 3 · not yet recruiting Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811297Phase 1/Phase 2 · not yet recruiting A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212274Phase 2 · active not recruiting Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139056Phase 1 · recruiting Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329570Phase 1/Phase 2 · suspended Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410248Phase 1 · recruiting Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613841early Phase 1 · recruiting Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946680Phase 1 · not yet recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989086NA · recruiting FearLess in NeuroOncology · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644312Phase 2 · not yet recruiting Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952598Phase 2 · suspended Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839379recruiting Targeted Pediatric High-Grade Glioma Therapy · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981940Phase 2 · active not recruiting A Study of Abemaciclib in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894225Phase 2 · recruiting Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337686Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657576Phase 1 · completed Trial of C134 in Patients With Recurrent GBM · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04677049Phase 1/Phase 2 · active not recruiting Study of Niacin in Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356973Phase 2 · recruiting Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07384884NA · recruiting Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188535NA · recruiting Serial MRI Scans During Radiation Therapy · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Adult Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215910Phase 3 · recruiting Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161974Phase 2 · recruiting Study of Olutasidenib and Temozolomide in HGG · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180927Phase 1/Phase 2 · not yet recruiting DLL3 CAR-T Therapy Targeting Brain Tumors · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Cerebellar Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201873Phase 1 · completed Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05226494Phase 1 · active not recruiting Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796061Phase 1 · not yet recruiting Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02179086Phase 2 · active not recruiting Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181684NA · active not recruiting LITT Followed by Hypofractionated RT for Recurrent Gliomas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07420543active not recruiting Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975829Phase 4 · active not recruiting Pediatric Long-Term Follow-up and Rollover Study · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409584recruiting Mental Health and Suicidality in Glioblastoma Patients in Germany · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501156Phase 1/Phase 2 · not yet recruiting H3K27M-specific Immune Effector Cells Targeting DMG/DIPG · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789379Phase 2 · not yet recruiting Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791264Phase 1 · not yet recruiting FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778602early Phase 1 · not yet recruiting Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788430NA · not yet recruiting Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076472early Phase 1 · recruiting Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579208Phase 1 · recruiting A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170141Phase 1 · terminated Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214392Phase 1 · active not recruiting Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096481Phase 2 · recruiting PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463848Phase 2 · active not recruiting Surgical Pembro +/- Olaparib w TMZ for rGBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954636recruiting Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209241Phase 1 · active not recruiting Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485049early Phase 1 · recruiting BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Adult Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658279NA · active not recruiting Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775534NA · not yet recruiting Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02977780Phase 2 · recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06108206active not recruiting Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06556563Phase 3 · recruiting EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762716Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047264NA · recruiting Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04903795Phase 1 · recruiting BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319027Phase 2 · recruiting Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767110Phase 1/Phase 2 · not yet recruiting Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769918NA · not yet recruiting Hypoxia-targeted Radiotherapy Boost for GBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05030298Phase 1 · recruiting Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095376Phase 3 · active not recruiting Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607407Phase 2 · suspended Methimazole in Patients With Progressive Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859334Phase 2 · active not recruiting Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | WHO Grade 3 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492486Phase 2 · recruiting Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632236Phase 1 · active not recruiting 5G-EMERALD: Amivantamab in Malignant Brain Tumours · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894979Phase 1 · active not recruiting Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Childhood Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07091864NA · recruiting Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243340Phase 1/Phase 2 · recruiting A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06344130Phase 1 · recruiting Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03389802Phase 1 · completed Phase I Study of APX005M in Pediatric Central Nervous System Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05450744Phase 1 · active not recruiting 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476939Phase 3 · recruiting Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186401Phase 1 · recruiting Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614855Phase 1 · active not recruiting A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052877recruiting The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244995NA · active not recruiting Mind-Body Intervention in Glioma Couples · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161519Phase 1/Phase 2 · recruiting PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544992Phase 1 · recruiting Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083512recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739372NA · completed Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544526Phase 1 · recruiting CAR T Cells to Target GD2 for DMG · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100730Phase 3 · recruiting Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758062Phase 2 · not yet recruiting Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197934Phase 1 · active not recruiting WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Anaplastic Astrocytoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469075Phase 2 · active not recruiting Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074756NA · recruiting A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501559Phase 1/Phase 2 · recruiting A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754734Phase 2 · not yet recruiting STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455557Phase 2 · active not recruiting SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761070Phase 3 · completed Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173829recruiting A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733674Phase 1 · recruiting Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751744Phase 1/Phase 2 · not yet recruiting Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862430Phase 2 · active not recruiting A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730869NA · completed Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086497NA · recruiting WBSI Guided Personalized Delivery of TTFields · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565118Phase 1 · recruiting Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003542Phase 2 · recruiting A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708352Phase 2 · recruiting A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748299available NuvOx Expanded Access · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643549Phase 1/Phase 2 · recruiting Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680439Phase 2 · recruiting Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03868943Phase 2 · terminated Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099797Phase 1 · recruiting C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624371Phase 1 · recruiting Atovaquone Combined With Radiation in Children With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06069726Phase 2 · recruiting A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206849Phase 2 · not yet recruiting Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) · condition mapped ONTOLOGY_EXACT · 2,053 trials mapped (658 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739017Phase 1 · not yet recruiting OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297125active not recruiting Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598244Phase 1 · active not recruiting Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970447Phase 2/Phase 3 · recruiting A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555577Phase 1 · active not recruiting Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05781321Phase 2 · active not recruiting Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464925Phase 1 · recruiting A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma · condition mapped ALIAS · 2,053 trials mapped (658 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735819Phase 2 · not yet recruiting Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05023551early Phase 1 · active not recruiting Study of DSP-0390 in Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 2,053 trials mapped (658 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |